日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Zingerone treats postmenopausal osteoporosis via increased ferroptosis sensitivity by p53-mediated regulation of SAT1 and GPX4 expression.

姜酮通过 p53 介导的 SAT1 和 GPX4 表达调节,增加铁死亡敏感性,从而治疗绝经后骨质疏松症。

Li Hao, Cao Fangming, Liu Dian, Tao Lin

Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis

三种抗氧化防御系统与绝经后骨质疏松症的发生发展

Yang, Keda; Cao, Fangming; Xue, Yuchuan; Tao, Lin; Zhu, Yue